Sellas to present new preclinical SLS009 data for pancreatic cancer
Sellas Life Sciences said three abstracts for SLS009 (Tambiciclib) have been accepted for poster presentation at a major oncology conference.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.